Stryker (NYSE:SYK) said today that it closed a pair of acquisitions, putting a bow on its $2.7 billion buyout of Sage Products and the deal for Synergetics‘s (NSDQ:SURG) neurostimulation assets for an undisclosed amount.
The deal for Sage Products, which makes a line of disposable devices designed to reduce so-called “never events” in intensive care and surgical settings, was announced Feb. 1.
The Sage lineup is expected to add to adjusted earnings per share this year and down the road, prompting the Kalamazoo, Mich.-based company to boost its adjusted earnings per share outlook by 5¢, to $5.55 to $5.75.
Nine days after revealing the Sage deal, Kalamazoo, Mich.-based Stryker said it would add the Synergetics Malis generator and Spetzler Malis disposable forceps to its existing Sonopet tips and RF generator.
That business is expected to be neutral to Stryker’s 2016 adjusted EPS.